Xinyu Yang

发表

One Shoot, Two Birds: Alleviating Inflammation Caused by Ischemia/Reperfusion Injury to Reduce the Recurrence of Hepatocellular Carcinoma

D. Lu, Hao-Lun Chen, Chiyu He, 2022, Frontiers in Immunology.

The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases

D. Lu, Xiao Xu, Jianyong Zhuo, 2020, International journal of biological sciences.

Liver Organoids, Novel and Promising Modalities for Exploring and Repairing Liver Injury

Shusen Zheng, Hao Chen, Xu‐yong Wei, 2022, Stem Cell Reviews and Reports.

Advanced therapies for congenital biliary tract malformation: from bench to bedside

Hao Chen, D. Lu, Yixuan Shao, 2022, iLIVER.

Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer

Shusen Zheng, Hao Chen, Xu‐yong Wei, 2022, Redox biology.

Identification of an IL-4-Related Gene Risk Signature for Malignancy, Prognosis and Immune Phenotype Prediction in Glioma

Chao Tang, Xinyu Yang, Ying Qi, 2022, Brain sciences.

Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation

Shusen Zheng, Hao Chen, Xu‐yong Wei, 2021, Cell proliferation.

Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.

Shusen Zheng, Xu‐yong Wei, D. Lu, 2020, Cancer biomarkers : section A of Disease markers.

Double-negative T cells: a promising avenue of adoptive cell therapy in transplant oncology

Hao Chen, D. Lu, Chiyu He, 2023, Journal of Zhejiang University-SCIENCE B.

Single-cell analysis reveals a pathogenic cellular module associated with early allograft dysfunction after liver transplantation

Shusen Zheng, Penghui Yang, Xin Shao, 2022, bioRxiv.

Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma

Shusen Zheng, Hao Chen, Xu‐yong Wei, 2023, Frontiers in Oncology.

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib

Haiyang Xie, Shusen Zheng, Xu‐yong Wei, 2021, Cell Death & Disease.

Fibroblast growth factor 21 (FGF21) attenuates tacrolimus-induced hepatic lipid accumulation through transcription factor EB (TFEB)-regulated lipophagy

Xu‐yong Wei, D. Lu, Zhensheng Zhang, 2023, Journal of Zhejiang University-SCIENCE B.

Finding the Right Balance in Pregnancy After Liver Transplantation: The Graft Function Should Also Be Taken Into Account.

Hao Chen, Xiao Xu, Xinyu Yang, 2022, The American journal of gastroenterology.

FGF21-mediated autophagy: Remodeling the homeostasis in response to stress in liver diseases

Hao Chen, D. Lu, Chiyu He, 2023, Genes & diseases.

Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinoma.

D. Lu, Chiyu He, Jianyong Zhuo, 2024, Transplant immunology.

TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinoma.

Shusen Zheng, Hao Chen, Beicheng Sun, 2023, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Integrated multi-omic analysis identifies fatty acid binding protein 4 as a biomarker and therapeutic target of ischemia–reperfusion injury in steatotic liver transplantation

D. Lu, Xinyu Yang, Binhua Pan, 2024, Cellular and molecular life sciences : CMLS.